Social Media Constructs Off-Label Ozempic Use
The growing discussion surrounding off-label drug use has sparked complex debates across medical, social, and ethical domains. Ozempic-a medication originally developed for managing type 2 diabetes-has become a prominent example. A recent study by Kartal and Günaltay (2025) analyzes the social construction of off-label Ozempic use as portrayed on social media, highlighting how digital environments shape public perceptions and behaviors regarding pharmaceutical consumption beyond prescribed indications.
Ozempic, chemically known as semaglutide, regulates blood glucose levels in diabetic patients as a glucagon-like peptide-1 (GLP-1) receptor agonist. However, its off-label use-notably for weight loss-has gained viral attention through anecdotal testimonials, influencer endorsements, and peer exchanges on platforms like Twitter, Instagram, and TikTok. This demonstrates social media’s capacity to disseminate medical narratives outside of traditional regulatory verification,creating new health discourses.The study employs qualitative content analysis to map thematic patterns and rhetorical strategies within these online conversations.
A central insight from Kartal and Günaltay’s research is how social media constructs an choice form of drug legitimacy. Unlike traditional biomedical paradigms based on randomized controlled trials and regulatory approvals, social media utilizes experiential knowledge as authority. Users share personal success stories, frequently enough with before-and-after images, creating persuasive narratives that frame Ozempic as a transformative tool for weight management and self-image enhancement. This prioritizes subjectivity and lived experience over clinical endorsement, democratizing but complicating health knowledge dissemination.
The study examines how Ozempic off-label use is normalized and valorized online. Hashtags, viral challenges, and meme culture embed the drug within lifestyle discourses, shifting its perception from a medical intervention to a desirable aesthetic enhancement. This intersects with sociocultural trends prioritizing slimness and health optimization. The research shows how symbolic capital gained through participation in these digital communities reinforces drug desirability, potentially influencing pharmaceutical demand and self-medication practices.
Kartal and Günaltay also address the ethical and public health implications of this social construction. Off-label consumption without medical supervision carries risks,including adverse side effects and interactions that lay consumers may not understand. The spread of unregulated health claims can undermine public trust in healthcare systems and regulatory bodies, complicating safe medication practices. This tension reflects a critical challenge in contemporary pharmacoepidemiology where digital culture and medical governance intersect.
Methodologically, the authors use discourse analysis to critically examine the linguistic and visual elements shaping Ozempic’s online portrayal. The analysis reveals a nuanced interplay between persuasive rhetoric, emotional appeals, and visual semiotics that collectively establish Ozempic’s desirability beyond its indicated use. This multimodal approach captures the complexity and dynamism of online health narratives.